The Platform Group AG (TPG.DE), a software solutions provider, on Friday announced that it is in advanced negotiations to acquire three companies operating pharmaceutical platforms in Germany, Austria, and the Czech Republic.
Letters of intent were signed in August, with purchase agreements targeted for September.
The acquisitions, valued in the double-digit million-euro range, are expected to add annual revenue in the low three-digit million-euro range, with an EBITDA margin of 4% to 6%.
The Platform Group, which entered the pharmaceutical sector in 2021 with its stake in ApoNow, said the move is aimed at significantly expanding its presence in the market.
To finance the transactions, the company is considering an increase of its existing 2024/2028 corporate bond ISIN: NO0013256834.
On Thursday, The Platform Group closed trading at EUR 8.42 on the XETRA.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.